Wave Life Sciences Ltd (WVE)

May 04, 2025

Renaissance Technologies LLC Lowers Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

May 04, 2025

May 04, 2025

Invesco Ltd. Increases Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

May 04, 2025

May 03, 2025

Wells Fargo & Company MN Purchases 22,873 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

May 03, 2025

May 02, 2025

WVE Shares Experience Surge in Value - knoxdaily.com

May 02, 2025

May 02, 2025

Cantor Fitzgerald Predicts WVE FY2025 Earnings - Defense World

May 02, 2025

May 01, 2025

Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

May 01, 2025

May 01, 2025

Wave Life Sciences to Host Webcast for First Quarter 2025 Financial Results and Business Updates - Nasdaq

May 01, 2025

May 01, 2025

Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025 - GlobeNewswire

May 01, 2025

May 01, 2025

RNA Medicine Pioneer Wave Life Sciences Sets Q1 2025 Earnings Call for May 8 - Stock Titan

May 01, 2025

May 01, 2025

Cantor Fitzgerald Initiates Coverage on Wave Life Sciences (NASDAQ:WVE) - Defense World

May 01, 2025

Apr 30, 2025

Wave Life Sciences Ltd (WVE) Stock: From Low to High in 52 Weeks - investchronicle.com

Apr 30, 2025

Apr 30, 2025

Wave Life Sciences Ltd (NASDAQ: WVE): Why Investors Shouldn’t Ditch WVE Stock In 2025 - Marketing Sentinel

Apr 30, 2025

Apr 29, 2025

The Analyst Verdict: WAVE Life Sciences In The Eyes Of 4 Experts - Benzinga

Apr 29, 2025

Apr 29, 2025

Wave Life Sciences Ltd (WVE) looking to reclaim success with recent performance - Sete News

Apr 29, 2025

Apr 29, 2025

Cantor Fitzgerald sets WAVE Life Sciences stock at Overweight By Investing.com - Investing.com India

Apr 29, 2025

Apr 29, 2025

Cantor Fitzgerald Initiates Wave Life Sciences at Overweight With $10 Price Target - marketscreener.com

Apr 29, 2025

Apr 29, 2025

Wave Life Sciences (WVE) Receives Overweight Rating and $10 Pric - GuruFocus

Apr 29, 2025

Apr 28, 2025

Wedbush analysts initates an Outperform rating for Wave Life Sciences Ltd (WVE) - knoxdaily.com

Apr 28, 2025

Apr 28, 2025

Can you now get a good deal on Wave Life Sciences Ltd’s shares? - uspostnews.com

Apr 28, 2025

Apr 28, 2025

Duchenne Muscular Dystrophy Treatment Market Growth, Trends & - openPR.com

Apr 28, 2025

Apr 25, 2025

Check Out Wave Life Sciences Ltd (WVE)’s Trade Data Rather Than the Analysts’ Views - Sete News

Apr 25, 2025

Apr 25, 2025

Analysts Say Wave Life Sciences Ltd (NASDAQ:WVE) Can Really Get To 36 In 12 Months - Marketing Sentinel

Apr 25, 2025

Apr 24, 2025

A stock that deserves closer examination: Wave Life Sciences Ltd (WVE) - uspostnews.com

Apr 24, 2025

Apr 24, 2025

Daily Market Movement: Wave Life Sciences Ltd (WVE) Sees a 3.51 Increase, Closing at 6.79 - DWinneX

Apr 24, 2025

Apr 24, 2025

Russell Investments Group Ltd. Purchases 43,398 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Apr 24, 2025

Apr 23, 2025

Wave Life Sciences Ltd (WVE) rating initates by Wedbush - knoxdaily.com

Apr 23, 2025

Apr 22, 2025

Wave Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Rating of “Buy” by Brokerages - Defense World

Apr 22, 2025

Apr 21, 2025

(WVE) Investment Report - news.stocktradersdaily.com

Apr 21, 2025

Apr 21, 2025

Wave Life Sciences Ltd. (NASDAQ:WVE) Short Interest Update - Defense World

Apr 21, 2025

Apr 19, 2025

Alliancebernstein L.P. Has $1.12 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Apr 19, 2025

Apr 18, 2025

Franklin Resources Inc. Trims Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Apr 18, 2025

Apr 17, 2025

Wave Life Sciences Ltd. (NASDAQ:WVE) Holdings Raised by Geode Capital Management LLC - Defense World

Apr 17, 2025

Apr 15, 2025

Will Wave Life Sciences (NASDAQ:WVE) Spend Its Cash Wisely? - Yahoo

Apr 15, 2025

Apr 13, 2025

Vanguard Group Inc. Raises Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Apr 13, 2025

Apr 11, 2025

Wave Life Sciences (WVE) Price Target Reduced by B. Riley Amid FDA Timeline Concerns | WVE Stock News - GuruFocus

Apr 11, 2025

Apr 10, 2025

Wave Life Sciences (WVE) Price Target Reduced by B. Riley Amid F - GuruFocus

Apr 10, 2025

Apr 10, 2025

B. Riley Adjusts Wave Life Sciences' Price Target to $19 From $22, Keeps Buy Rating - MarketScreener

Apr 10, 2025

Apr 09, 2025

Wave Life Sciences (NASDAQ:WVE) Coverage Initiated by Analysts at Wedbush - Defense World

Apr 09, 2025

Apr 08, 2025

Wedbush sets $18 target for WAVE Life Sciences stock By Investing.com - Investing.com India

Apr 08, 2025

Apr 08, 2025

Wedbush sets $18 target for WAVE Life Sciences stock - Investing.com Australia

Apr 08, 2025

Apr 08, 2025

Wedbush Initiates Wave Life Sciences at Outperform With $18 Price Target - marketscreener.com

Apr 08, 2025

Apr 08, 2025

Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Acquired by Corebridge Financial Inc. - Defense World

Apr 08, 2025

Apr 07, 2025

KLP Kapitalforvaltning AS Acquires New Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Apr 07, 2025

Apr 04, 2025

(WVE) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Apr 04, 2025

Apr 04, 2025

Wave Life Sciences Ltd.'s (NASDAQ:WVE) 41% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio - simplywall.st

Apr 04, 2025

Apr 03, 2025

RBC Cuts Price Target on Wave Life Sciences to $10 From $14, Keeps Sector Perform, Speculative Risk - MarketScreener

Apr 03, 2025

Mar 31, 2025

Wave Life Sciences’ SWOT analysis: RNA editing pioneer faces challenges in genetic medicine stock - Investing.com India

Mar 31, 2025

Mar 31, 2025

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics - Yahoo Finance

Mar 31, 2025

Mar 31, 2025

What is Leerink Partnrs’ Estimate for WVE Q1 Earnings? - Defense World

Mar 31, 2025

Mar 28, 2025

Promising Genomics & Synthetic Biology Stocks to Consider in 2025 - Yahoo Finance

Mar 28, 2025

Mar 28, 2025

HC Wainwright Reaffirms “Buy” Rating for Wave Life Sciences (NASDAQ:WVE) - Defense World

Mar 28, 2025

Mar 27, 2025

Wave Life Sciences: Potential For Accelerated Approval Pathway With WVE-N531 (NASDAQ:WVE) - Seeking Alpha

Mar 27, 2025

Mar 27, 2025

WAVE Life Sciences stock holds buy rating, $22 target from H.C. Wainwright - Investing.com Australia

Mar 27, 2025

Mar 27, 2025

Wave Life Sciences unveils Phase II data for DMD therapy, WVE-N531 - Yahoo Finance

Mar 27, 2025

Mar 27, 2025

Wave Life Sciences (WVE) Stock Jumps 6.1%: Will It Continue to Soar? - Nasdaq

Mar 27, 2025